Live Breaking News & Updates on Robertp Pinkas

Stay updated with breaking news from Robertp pinkas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Boosting CAR-T cell therapies from under the skin

CAR-T cell therapies are transforming the treatment of previously incurable blood cancers, but a large proportion of patients still responds only poorly or not at all to them, calling for new strategies to overcome this challenge. Now, a research team has developed a simple intervention in the form of a biodegradable scaffold material called T-cell enhancing scaffolds (TES) that can be locally injected under the skin and used to restimulate CAR-T cells after their administration. This increased their therapeutic efficacy and significantly curbed tumor growth and prolonged animal survival in an aggressive mouse lymphoma model. ....

United States , Miguel Sobral , Robertp Pinkas , Yoav Binenbaum , Yutong Liu , Donald Ingber , Dave Mooney , David Mooney , David Zhang , Joshua Brockman , Kwasi Adu Berchie , Drug Administration , Harvard Johna Paulson School Of Engineering , Wyss Institute At Harvard University , National Institutes Of Health , University Of Wisconsin , Wyss Institute , Biologically Inspired Engineering , Harvard University , Harvard John , Applied Sciences , Nature Biomedical , Wyss Founding Core Faculty , Family Professor , Postdoctoral Fellow , Assistant Professor ,

Expanding a lymph node, boosting a vaccine

For the first time, researchers from the&nbsp;Wyss Institute for Biologically Inspired Engineering at Harvard University,&nbsp;Harvard John A. Paulson School of Engineering and Applied Sciences&nbsp;(SEAS), and&nbsp;Genentech<u>, a member of the Roche Group,</u>&nbsp;found a way to enhance and extend LN expansion, and study how this phenomenon affects both the immune system and efficacy of vaccinations against tumors. While the oversized LNs maintained a normal tissue organization, they displayed altered&nbsp;mechanical features&nbsp;and hosted higher numbers of various immune cell types that commonly are involved in immune responses against pathogens and cancers. Importantly, &ldquo;jump-starting&rdquo; lymph node expansion prior to administering a traditional vaccine against a melanoma-specific model antigen led to more effective and sustained anti-tumor responses in mice.&nbsp; ....

Massachusetts Institute Of Technology , United States , Tufts University , Spaulding Rehabilitation Hospital , University Of Massachusetts Medical School , Boston University , Benjamin Freedman , Katherine Williams , Maxence Dellacherie , Shannon Turley , Christina Tringides , Hamza Ijaz , Joel Gutierrez Estupinan , Giovanni Bovone , Alberto Elosegui Artola , Benjamin Boettner , Shawn Kang , Miguel Sobral , Robertp Pinkas , Alexander Najibi , Donald Ingber , David Mooney , Harvard Johna Paulson School Of Engineering , Farber Cancer Institute , Arts Sciences , National Institutes Of Health Cancer Institute ,